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INTRODUCTION
A positive direct antiglobulin test (DAT) is an important
finding in the diagnosis of autoimmune hemolytic anemia
(AIHA). However, red blood cell antibodies of the immuno-
globulin A (IgA) class are not common and most of the lab-
oratories use only anti-human IgG and C3d reagents for rou-
tine DAT. Therefore, the detection of IgA autoantibodies as
a causative antibody for AIHA is difficult.
Warm autoantibodies are usually nonspecific. They may
lack reactivity with Rhnullcells (1), or rarely are specific for
one or more of the common Rh phenotypes. However, IgA
autoantibodies that have specificities against antigens within
the Rh system, such as anti-C (2), anti-e (3), anti-Ce+anti-e
(4), anti-E (5), and autoanti-Gerbich (6) have been reported.
As far as we can determine, there has been no case report
on the warm AIHA associated with IgA that have specifici-
ties against E and c antigens in Korea. We report here a case
of a severe AIHA associated with a strong reactivity by anti-
IgA and weak reactivity by anti-IgG reagent in the DAT, and
free anti-E and anti-c autoantibodies of IgA and IgG classes
in the serum.
CASE REPORT
A 13-yr-old male patient was admitted with a 2-day his-
tory of fever, nausea, jaundice, and fatigue. Two weeks prior
to admission, he experienced flu-like symptoms. Physical
examination revealed an acutely ill appearance with pallor,
icteric sclerae, and hepatomegaly (5 cm) below the costal
margin, but no splenomegaly. He had no history of anemia,
jaundice or blood transfusion.
The laboratory data were as follows. The hemoglobin was
5.3 g/dL, hematocrit 14.8%, mean corpuscular volume 123.2
fL and the leukocyte count was 20,500/ L with myelocyte
2%, metamyelocyte 2%, band neutrophil 1%, segmented
neutrophil 65%, lymphocyte 25%, monocyte 4%, eosinophil
1%, and 14 nucleated RBCs per 100 leukocytes. The platelet
count was 460,000/ L and the corrected reticulocyte count
was 21.3%. The peripheral blood smear revealed severe sphe-
rocytosis, polychromasia and RBC agglutination (Fig.1). An
increased osmotic fragility was observed and the bone marrow
revealed erythroid hyperplasia. Total protein and albumin
were 7.2 g/dL and 4.6 g/dL, total bilirubin/direct bilirubin
8.3/1.1 mg/dL, lactate dehydrogenase 1,710 U/L, and the
haptoglobin was undetectable (≤5.8 mg/dL). The urine he-
moglobin was positive (3+). The cold agglutinin titer was
1:64 and Mycoplasma antibody was negative.
The DAT was weakly reactive (1+), and anti-E and anti-c
antibodies were detected in the antibody identification test
using polyspecific AHG reagents by gel column (DiaMed-
ID, Cressier/Morat, Swizerland). However, the finding of
weakly reactive DAT could not fully explain the patient’s
severe hemolytic anemia. When an anti-IgA reagent (Dia
Med-ID, Cressier/Morat, Swizerland) was used, the strongly
reactive (4+) DAT was observed. Free anti-E and anti-c au-
toantibodies were also detected in the serum by the tube
Young Ae Lim, Moon Kyu Kim*, 
Bong Hak Hyun
Department of Laboratory Medicine and Pediatrics*,
Ajou University School of Medicine, Suwon, Korea
Address for correspondence
Young Ae Lim, M.D.
Department of Laboratory Medicine, Ajou University
School of Medicine, San-5 Woncheon-dong, 
Paldal-gu, Suwon 442-721, Korea
Tel : +82.31-219-5786, Fax : +82.31-219-5778
E-mail : limyoung@madang.ajou.ac.kr
708
J Korean Med Sci 2002; 17: 708-11
ISSN 1011-8934
Copyright � The Korean Academy
of Medical Sciences
Autoimmune Hemolytic Anemia Predominantly Associated with
IgA Anti-E and Anti-c
A patient with warm autoimmune hemolytic anemia (AIHA) due to predominance
of immunoglobulin A (IgA) with an Rh specificity, considered to be the first case
in Korea, is described. A 13-yr-old male patient with severe hemolytic anemia
showed a weak reactivity (1+) in the direct antiglobulin test (DAT) by using anti-
IgG antiglobulin reagent. This finding, however, could not fully explain the patient's
severe AIHA. When anti-IgA reagent was used for the DAT, strong reactivity (4+)
was observed and free anti-E and anti-c autoantibodies were also detected by
anti-IgA and anti-IgG reagents. The patient's hemoglobin began to rise with the
administration of steroids. Because RBCs coated with multiple types of immuno-
globulins are associated with more severe hemolysis than those only with IgG,
the DATs using anti-IgA and other reagents are needed for the correct diagnosis
when the result of DAT is not compatible with patient's clinical manifestations.
Key Words : Anemia, Hemolytic, Autoimmune; Direct Antiglobulin Test; Anti-IgA
Received : 3 September 2001
Accepted : 3 November 2001AIHA with IgA anti-E and Anti-c 709
method only in antiglobulin phase with anti-IgA (Monospe-
cific Coombssera Anti-IgA, Biotest AG, Germany) and panel
cells (DiaMed-ID, Cressier/Morat, Swizerland) (Table 1).
DATs, however, were negative by the reagents (DiaMed-ID,
Cressier/Morat, Swizerland) of anti-IgM, anti-C3d and anti-
C3c (Fig. 2). The patient’s Rh subgroup type was CcDEe
with pre-transfusion specimen. IgA and IgG eluates showed
reactivities only against RBCs containing E and c antigens
(Table 1). 
On the day of admission, two units of crossmatching com-
patible and E and c antigen negative packed RBCs were ad-
ministered. However, the hemoglobin level dropped further
to 4.9 g/dL and this low level was maintained until the ad-
ministration of steroids on the 5th hospital day when we could
diagnose IgA autoantibodies of AIHA as a cause of the dis-
ease. Before steroid treatment was started, ceftriaxone, rox-
ithromycin and Gabexate mesylate were administrated for
control of suspicious Mycoplasma infection and disseminat-
ed intravascular coagulation. Relief of jaundice followed and
the hemoglobin rose to 8.4 g/dL. He was discharged on the
Fig. 1. Peripheral blood smear (Wright stain,×1,000) shows
spherocytosis, polychromasia, red blood cell micro-agglutina-
tion (arrow) and two erythroblasts. 
Fig. 2. The results of direct antiglobulin test by gel column (Dia
Med-ID, Cressier/Morat, Swizerland) shows weak reactivity (1+)
in anti-IgG, strong reactivity (4+) in anti-IgA and no reactivities
in anti-IgM, anti-C3c and anti-C3d.
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Table 1. Reactivity of antibody identification tests (antihuman globulin phase) in serum and eluates
Panel cells: ID-DiaPanel (DiaMed-ID, Cressier/Morat, Swizerland). 
Anti-IgG by gel columna: DiaMed-ID, Cressier/Morat, Swizerland; Anti-IgA by tube testb: monospecific Coombssera anti-IgA, Biotest AG, Germany;
ND
c: Eluate could not be reacted with panel cells, however, eluates showed reactivities against screening RBCs containing E and c antigens using
anti-IgG reagent . 
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12th hospital day. The steroid was tapered off and was discon-
tinued two weeks later. Three weeks after the discharge, his
hemoglobin was elevated to 11.3 g/dL, mean corpuscular
volume decreased to 97.3 fL and the corrected reticulocyte
count decreased to 2.1%, but the cold agglutinin titer re-
mained at 1:128. The DAT was still weakly reactive by using
anti-IgG reagent (1+) and not done by using anti-IgA rea-
gent, but the free antibodies were not detected in the serum
by using anti-IgG and anti-IgA antiglobulin reagent.
DISCUSSION
The initial diagnosis of this patient with warm AIHA was
not easy. Hereditary spherocytosis was seriously considered
because of severe spherocytosis and increased osmotic fragili-
ty. Since positive DATs with reactivities ‘1+’ or less can be
observed in apparently normal subjects, the finding of weak-
ly positive DAT by anti-IgG reagent could not explain the
patient’s severe intravascular hemolysis. Thus, it was neces-
sary to use other means to detect responsible autoantibodies.
IgA autoantibodies in many patients have been reported
to be idiopathic (2) contrary to this case. IgA autoantibodies
of the RBCs are usually warm-reacting and the clinical course
of the patients with such autoantibodies is similar to that of
patients with IgG antibodies (4). Whether the warm-react-
ing IgA autoantibodies can activate the complement system
of their own is controversial. Several studies (2, 7) have shown
that IgA antibodies coating RBCs may activate the comple-
ments and complement components (C3) on the RBCs, result-
ing in severe intravascular hemolysis, but not in other reports
(3, 5) as in our case. Salama et al. (8) reported that the DAT
was strongly reactive for IgA (weakly reactive for IgG) and
negative for complement as in our case. They presented the
circumstantial evidence for the involvement of reactive hemol-
ysis, i.e., C3-independent binding of the cytolytic C5b-9 com-
plement complex to bystander RBCs inducing intravascular
hemolysis. IgA is also able to activate complements by the
alternative pathway (9).
IgA and IgM were usually found in association with IgG.
Although only IgA was found in 0.8-2.0% of AIHA (10),
the 14% of IgA autoantibodies was reported in the warm-
type AIHA, such as IgG+IgA (5.8%), and IgG+IgM+IgA
(8%) using sensitive enzyme-treated DAT (2). The presence
of more than one type of antibodies on RBCs, even when un-
detected by agglutination methods, has been reported to be
the major cause of hemolysis along with other factors, such
as the quantity of bound IgG, the IgG subclass pattern, and
complement (2, 11). IgA acts synergistically with other im-
munoglobulins, usually IgG. Therefore, to predict the prog-
nosis of patients with AIHA, it is important to evaluate not
only the reactivity of DAT by anti-IgG reagent but also the
existence of other classes of immunoglobulin as a causative
autoantibody. In our case, the patient had IgA- and IgG-coat-
ing RBCs and showed severe intravascular hemolysis.
The patients with multiple classes of immunoglobulins
coated RBCs were reported to respond less successfully to
steroids, and most of them was revealed to have no underly-
ing disease (11). However, the present patient had AIHA of
an acute transient type, which is known to be more frequent
among young children and responds well to therapy (12).
The diagnosis of the AIHA can be overlooked when the
routine DAT using polyspecific reagent containing anti-IgG
and anti-C3d is negative or weakly positive. Therefore, the
DAT using anti-IgA or other reagents is needed when the
results of the DAT are not compatible with patient’s clinical
manifestations. Immediate steroid therapy must be started
when the warm AIHA is suspected, even if the routine DAT
shows weak reactivity, since severe hemolysis may occur when
the small amount of detectable immunoglobulins act syner-
gically with undetected immunoglobulin classes as in the
present case.
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